Corvus Pharmaceuticals, Inc.
HUMANIZED ANTI-CD73 ANTIBODIES
Last updated:
Abstract:
Provided herein are, inter alia, humanized 1E9 antibodies capable of binding CD73. The humanized antibodies are useful for the treatment of cancer. Further provided are nucleic acids encoding humanized 1E9 antibodies and methods of inhibiting cell proliferation using the humanized antibodies provided herein.
Status:
Application
Type:
Utility
Filling date:
24 Sep 2020
Issue date:
19 Aug 2021